High incidence of unplanned pregnancy after antiretroviral therapy initiation: Findings from a prospective cohort study in south africa

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Schwartz, Sheree R ^a,b   Rees, Helen ^a   Mehta, Shruti ^b   Venter, Willem Daniel Francois ^a   Taha, Taha E ^b   Black, Vivian ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ; NEVIRAPINE; CONTRACEPTIVE AGENT; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG USE; FEMALE; FOLLOW UP; HEALTH HAZARD; HEALTH SERVICE; HIGH RISK POPULATION; HORMONAL CONTRACEPTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PATIENT COUNSELING; PROSPECTIVE STUDY; RISK FACTOR; SOUTH AFRICA; TREATMENT DURATION; UNPLANNED PREGNANCY; VIRUS LOAD; HEALTH CARE PERSONNEL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; INCIDENCE; INTERPERSONAL COMMUNICATION; KAPLAN MEIER METHOD; PHYSIOLOGY; PREGNANCY; PREVALENCE; STATISTICS; TIME;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COMMUNICATION; CONTRACEPTIVE AGENTS; CONTRACEPTIVES, ORAL, HORMONAL; FEMALE; FOLLOW-UP STUDIES; HEALTH PERSONNEL; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; PREGNANCY; PREGNANCY, UNPLANNED; PREVALENCE; PROSPECTIVE STUDIES; SOUTH AFRICA; TIME FACTORS;

EID: 84860456123     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036039     Document Type: Article

References (29)

1. UNAIDS (2010) UNAIDS Report on the global AIDS epidemic 2010.
2. World Health Organization (2010) PMTCT strategic vision 2010-2015: preventing mother-to-child transmission of HIV to reach the UNGASS and Millennium Development Goals New York City.
3. Sweat MD, O'Reilly KR, Schmid GP, Denison J, de Zoysa I, (2004) Cost-effectiveness of nevirapine to prevent mother-to-child HIV transmission in eight African countries. AIDS (London, England) 18: 1661-1671.
4. Reynolds HW, Janowitz B, Homan R, Johnson L, (2006) The value of contraception to prevent perinatal HIV transmission. Sexually transmitted diseases 33: 350-356 doi:10.1097/01.olq.0000194602.01058.e1.
5. Ngure K, Heffron R, Mugo N, Irungu E, Celum C, et al. (2009) Successful increase in contraceptive uptake among Kenyan HIV-1-serodiscordant couples enrolled in an HIV-1 prevention trial. AIDS (London, England) 23 (Suppl 1): S89-S95 doi:10.1097/01.aids.0000363781.50580.03.
6. Kaida A, Laher F, Strathdee Sa, Money D, Janssen Pa, et al. (2010) Contraceptive use and method preference among women in Soweto, South Africa: the influence of expanding access to HIV care and treatment services. PloS one 5: e13868 doi:10.1371/journal.pone.0013868.
7. Cooper D, Moodley J, Zweigenthal V, Bekker L-G, Shah I, et al. (2009) Fertility intentions and reproductive health care needs of people living with HIV in Cape Town, South Africa: implications for integrating reproductive health and HIV care services. AIDS and behavior 13 (Suppl 1): 38-46 doi:10.1007/s10461-009-9550-1.
8. Kaida A, Laher F, Strathdee Sa, Janssen Pa, Money D, et al. (2011) Childbearing intentions of HIV-positive women of reproductive age in Soweto, South Africa: the influence of expanding access to HAART in an HIV hyperendemic setting. American journal of public health 101: 350-358 doi:10.2105/AJPH.2009.177469.
9. Nattabi B, Li J, Thompson SC, Orach CG, Earnest J, (2009) A systematic review of factors influencing fertility desires and intentions among people living with HIV/AIDS: implications for policy and service delivery. AIDS and behavior 13: 949-968 doi:10.1007/s10461-009-9537-y.
10. Gray RH, Wawer MJ, Serwadda D, Sewankambo N, Li C, et al. (1998) Population-based study of fertility in women with HIV-1 infection in Uganda. Lancet 351: 98-103 doi:10.1016/S0140-6736(97)09381-1.
11. Myer L, Carter RJ, Katyal M, Toro P, El-Sadr WM, et al. (2010) Impact of antiretroviral therapy on incidence of pregnancy among HIV-infected women in Sub-Saharan Africa: a cohort study. PLoS medicine 7: e1000229 doi:10.1371/journal.pmed.1000229.
12. Homsy J, Bunnell R, Moore D, King R, Malamba S, et al. (2009) Reproductive intentions and outcomes among women on antiretroviral therapy in rural Uganda: a prospective cohort study. PloS one 4: e4149 doi:10.1371/journal.pone.0004149.
13. Coutsoudis A, England K, Rollins N, Coovadia H, Newell M-L, et al. (2010) Women's morbidity and mortality in the first 2 years after delivery according to HIV status. AIDS (London, England) 24: 2859-2866 doi:10.1097/QAD.0b013e32834041b7.
14. Cooper ER, Charurat M, Mofenson L, Hanson IC, Pitt J, et al. (2002) Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. Journal of acquired immune deficiency syndromes 29: 484-494.
15. Department of Health SA (2004) National Antiretroviral Treatment Guidelines.
16. Zou G, (2004) A modified poisson regression approach to prospective studies with binary data. American journal of epidemiology 159: 702-706.
17. Schwartz SR, Mehta SH, Taha TE, Rees HV, Venter F, et al. (2012) High Pregnancy Intentions and Missed Opportunities for Patient-Provider Communication About Fertility in a South African Cohort of HIV-Positive Women on Antiretroviral Therapy. AIDS and behavior doi:10.1007/s10461-011-9981-3.
18. Rubin DB, (1987) Multiple Imputation for Nonresponse in Surveys. In: Rubin DB, editors. Hoboken, NJ, USA John Wiley & Sons, Inc doi:10.1002/9780470316696.
19. Abdool Karim SS, Richardson Ba, Ramjee G, Hoffman IF, Chirenje ZM, et al. (2011) Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women. AIDS (London, England) doi:10.1097/QAD.0b013e32834541d9.
20. Makumbi FE, Nakigozi G, Reynolds SJ, Ndyanabo A, Lutalo T, et al. (2011) Associations between HIV Antiretroviral Therapy and the Prevalence and Incidence of Pregnancy in Rakai, Uganda. AIDS research and treatment 2011: 519492 doi:10.1155/2011/519492.
21. Desgrées-Du-Loû A, Msellati P, Viho I, Yao A, Yapi D, et al. (2002) Contraceptive use, protected sexual intercourse and incidence of pregnancies among African HIV-infected women. DITRAME ANRS 049 Project, Abidjan 1995-2000. International journal of STD & AIDS 13: 462-468.
22. Cejtin HE, Kalinowski A, Bacchetti P, Taylor RN, Watts DH, et al. (2006) Effects of human immunodeficiency virus on protracted amenorrhea and ovarian dysfunction. Obstetrics and gynecology 108: 1423-1431 doi:10.1097/01.AOG.0000245442.29969.5c.
23. Reid SE, Dai JY, Wang J, Sichalwe BN, Akpomiemie G, et al. (2010) Pregnancy, contraceptive use, and HIV acquisition in HPTN 039: relevance for HIV prevention trials among African women. Journal of acquired immune deficiency syndromes 53: 606-613 doi:10.1097/QAI.0b013e3181bc4869.
24. Stringer EM, Kaseba C, Levy J, Sinkala M, Goldenberg RL, et al. (2007) A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus. American journal of obstetrics and gynecology 197: 144e1-e8 doi:10.1016/j.ajog.2007.03.031.
25. Morrison CS, Richardson BA, Mmiro F, Chipato T, Celentano DD, et al. (2007) Hormonal contraception and the risk of HIV acquisition. AIDS (London, England) 21: 85-95 doi:10.1097/QAD.0b013e3280117c8b.
26. Polis CB, Wawer MJ, Kiwanuka N, Laeyendecker O, Kagaayi J, et al. (2010) Effect of hormonal contraceptive use on HIV progression in female HIV seroconverters in Rakai, Uganda. AIDS (London, England) 24: 1937-1944 doi:10.1097/QAD.0b013e32833b3282.
27. El-Ibiary SY, Cocohoba JM, (2008) Effects of HIV antiretrovirals on the pharmacokinetics of hormonal contraceptives. The European journal of contraception & reproductive health care: the official journal of the European Society of Contraception 13: 123-132 doi:10.1080/13625180701829952.
28. Heffron R, Donnell D, Rees H, Celum C, Mugo N, et al. (2011) Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. The Lancet Infectious Diseases doi:10.1016/S1473-3099(11)70247-X.
29. Trussell J, (2004) Contraceptive efficacy. In: Hatcher RA, Trussel J, Stewart F, Nelson AL, Cates W, Guest F, editors. New York, NY Ardent Media In Contraceptive Technology. 19th ed.